Abstract
Ecologic studies have reported that solar ultraviolet radiation (UVR) exposure is associated with cancer, but little evidence is available from prospective studies. We aimed to assess the association between an objective measure of ambient UVR exposure and risk of total and site-specific cancer in a large, regionally diverse cohort (450,934 white, non-Hispanic subjects (50-71 years old) in the prospective NIH-AARP Diet and Health Study) after accounting for individual-level confounding risk factors. Estimated erythemal UVR exposure from satellite Total Ozone Mapping Spectrometer (TOMS) data from NASA was linked to the U.S. Census Bureau 2000 census tract (centroid) of baseline residence for each subject. We used Cox proportional hazards models adjusted for multiple potential confounders to estimate hazard ratios (HR) and 95% confidence intervals (CI) for quartiles of UVR exposure. Restricted cubic splines examined non-linear relationships. Over 9 years of follow-up, UVR exposure was inversely associated with total cancer risk (N=75,917; highest vs. lowest quartile, HR=0.97 (0.95, 0.99), p-trend<0.001). In site-specific cancer analyses, UVR exposure was associated with increased melanoma risk (highest vs. lowest quartile, HR=1.22 (1.13, 1.32), p-trend<0.001) and decreased risk of Non-Hodgkin’s lymphoma (HR=0.82 (0.74, 0.92)) and colon (HR=0.88 (0.82, 0.96)), squamous cell lung (HR=0.86 (0.75, 0.98)), pleural (HR=0.57 (0.38, 0.84)), prostate (HR=0.91 (0.88, 0.95)), kidney (HR=0.83 (0.73, 0.94)), and bladder (HR=0.88 (0.81, 0.96)) cancers (all p-trend<0.05). We also found non-linear associations for some cancer sites, including the thyroid and pancreas. Our results add to mounting evidence for the influential role of UVR exposure on cancer.
Keywords: Ultraviolet radiation, cancer, vitamin D, prospective
Introduction
Ecologic studies suggest that exposure to solar ultraviolet radiation (UVR) may protect against risks of several cancers 1, including colorectal, prostate, and female breast cancers, and subsequent epidemiologic studies also showed associations with these cancer sites 2-4 and others such as non-Hodgkin’s lymphoma (NHL) 5. The beneficial effects of sunlight against cancer may be due to vitamin D 6; solar UV-B exposure contributes to approximately 90% of serum vitamin D levels 7. Some studies suggest that high levels of dietary or circulating serum vitamin D are associated with lower cancer risk but results are inconsistent 8. In addition to vitamin D, UVR exposure may affect health due to other mechanisms 9.
Existing evidence is derived mostly from ecologic studies, which lack individual-level covariates and have frequently relied on geographic location such as latitude 10-11 as surrogate for sunlight exposure. Estimated ground-level UVR exposure (erythemal dose) from the Total Ozone Mapping Spectrometer (TOMS) dataset of the National Aeronautics and Space Administration (NASA) has been widely used in recent studies 3, 12 to better estimate potential UVR exposure. Few studies with individual-level data on UVR exposure and covariates have been conducted in diverse regions.
Here, we used the TOMS UVR estimates to prospectively examine the association between ambient residential UVR exposure and total and site-specific incident cancer risk in the National Institutes of Health (NIH)-AARP Diet and Health Study. We assessed the associations between a historically available objective measure of ambient UVR exposure and incident cancer in a large, regionally diverse population after accounting for individual lifestyle and other potentially confounding risk factors.
Materials and Methods
Study population
The NIH-AARP Diet and Health study has been described 13. Briefly, between 1995 and 1996, a self-administered questionnaire was mailed to 3.5 million AARP members between 50 and 71 years old and residing in six U.S. states (California, Florida, Louisiana, New Jersey, North Carolina, Pennsylvania) and two metropolitan areas (Atlanta, Detroit). The study was approved by the National Cancer Institute Institutional Review Board. This questionnaire elicited information on demographic characteristics, health-related behaviors, and dietary intake, and 566,399 completed the questionnaire in satisfactory detail and consented to be in the study. Subsequently, two more questionnaires were administered during follow-up. We excluded proxy-responders (15,760), subjects with cancer prior to baseline (51,234), those with calorie intake of more than two interquartile ranges from the median (4,417), and those who were missing age information (46). We excluded those who self-identified as any race or ethnicity other than white, non-Hispanic or had missing race/ethnicity information (43,445). We also excluded participants for whom we did not have geocoded baseline residence (563). The resulting cohort included 450,934 participants: 272,796 men and 178,138 women.
Follow-up and case ascertainment
The follow-up for incident cancer spanned from the day of study entry until diagnosis of cancer, death, loss to follow-up (those who moved out of the cancer catchment area), or the current end of incident cancer follow-up (31 December 2006). Cancer cases were identified by probabilistic record linkage with cancer registries in the original eight states or metropolitan areas and two additional states (Arizona, Texas) 14; cancers were identified by anatomic site and histologic code of the International Classification of Disease for Oncology, 3rd edition (ICD-O).
UVR exposure assessment
The NASA TOMS database (http://toms.gsfc.nasa.gov) provided daily information on a noon-time ground-level erythemal estimate on a 1° latitude by 1.25° longitude grid between 1978-1993 and 1996-2005. We assigned the ground-level erythemal exposure for each participant in the study by deterministic linkage of the census tract centroid of the residence at baseline to the closest point on the TOMS grid using ArcView 9.3 (Esri, Redlands, CA); the census tract for each subject was assigned spatially, based on the longitude and latitude coordinates from geocoding residential address. The erythemal exposure was averaged across all available measured days in the month of July because summer is when surface UVR is strongest, noise factors such as clouds and aerosols are not as influential 15, and when the TOMS UVR data are in better agreement with ground-based data 16. We used both continuous and quartiles of the erythemal exposure, defined as joules per square meter (J/m2) 17.
Covariate assessment
Additional exposure variables were derived from information provided in the baseline questionnaire, which included a 124-item food frequency questionnaire 13. Sex and age at baseline (used as a continuous variable) were self-reported. Body mass index (BMI) was calculated from self-reported baseline height and weight and was used as a continuous variable. Intakes of fruits, vegetable, red meat, and white meat were expressed as servings per day as defined by the U.S. MyPyramid equivalents database. Alcohol consumption was measured as drinks per day. We also categorized tobacco smoking, education, and two physical activity variables (usual routine physical activity throughout the day and vigorous physical activity). For each subject, we assigned the median household income for the 2000 census tract as a proxy measure of socioeconomic status. For all covariates, missing indicator variables were used for those who had missing values.
Statistical analysis
We first examined the cross-sectional association between ambient residential UVR exposure and self-reported history of non-melanoma skin cancer (assessed in 2004-2006 follow-up questionnaire) in a subset of the study participants (n=251,703) to verify that our measure of UVR exposure was valid. Logistic regression models were used to calculate odds ratios (ORs) and 95% confidence intervals (CI). This exploratory data analysis revealed the presence of residual spatial correlation in logistic regression models to explain non-melanoma skin cancer. We considered generalized additive models with a smoothed term that was a function of spatial coordinates using thin plate regression splines 18. We fitted models with the smoothed term based on longitude and latitude separately and together. Longitude alone was statistically significant without explaining the effect of UVR exposure (UVR exposure was related to longitude and latitude). We used this longitude function as the residual variation adjustment term in models for total cancer risk as well as organ-specific cancer risk. However, we noted that the term for residual spatial correlation was significant in only 22% of the models and did not substantially change the main effect estimates. Therefore, we omitted the spatial correlation term in all models presented here.
We used a Cox proportional hazards model adjusted for multiple potential confounders (listed in Table 1) considered important a priori to estimate hazard ratios (HR) and 95% CI per quartile of UVR exposure. Trends were measured based on the ordinal quartiles. We also examined the possibility of non-linear relationships between UVR exposure and select cancers non-parametrically using restricted cubic splines 19. All tests of statistical significance were two-sided.
Table 1.
NIH-AARP Study of Diet and Health cohort subject characteristics
| July erythemal exposure (J/m2)* |
|||||
|---|---|---|---|---|---|
| Cohort | ≤186.3 | >186.3-236.8 | >236.8-253.7 | >253.7 | |
| N | 450,934 | 118,344 | 105,843 | 106,356 | 120,391 |
| Male, n (%) | 272,796 (60.50) | 73,937 (62.48) | 64,481 (60.92) | 63,362 (59.58) | 71,016 (58.99) |
| Age at entry, mean (sd) | 62.07 (5.38) | 61.84 (5.44) | 61.88 (5.41) | 62.05 (5.34) | 62.46 (5.30) |
| BMI (kg/m2), mean (sd) | 27.05 (4.78) | 27.44 (4.86) | 26.98 (4.71) | 26.97 (4.80) | 26.79 (4.71) |
| Calories intake (kcal/day), mean (sd) | 1,836 (795) | 1,879 (803) | 1,855 (802) | 1,803 (783) | 1,805 (791) |
| Alcohol (drinks/day), mean (sd) | 0.94 (2.41) | 0.85 (2.27) | 0.84 (2.28) | 1.00 (2.46) | 1.06 (2.61) |
| Fruit (servings/day), mean (sd) | 1.16 (0.79) | 1.18 (0.79) | 1.11 (0.76) | 1.16 (0.78) | 1.20 (0.81) |
| Vegetables (servings/day), mean (sd) | 1.14 (0.58) | 1.13 (0.56) | 1.09 (0.55) | 1.15 (0.59) | 1.18 (0.62) |
| Red meat (servings/day), mean (sd) | 1.12 (0.69) | 1.14 (0.69) | 1.14 (0.67) | 1.10 (0.69) | 1.10 (0.71) |
| White meat (servings/day), mean (sd) | 0.65 (0.56) | 0.65 (0.56) | 0.61 (0.52) | 0.66 (0.55) | 0.69 (0.60) |
| Smoking** | |||||
| Never % | 34.69 | 35.92 | 35.24 | 34.79 | 32.89 |
| Former, ≤ 20 cigarettes/day % | 26.31 | 26.20 | 26.22 | 26.32 | 26.48 |
| Former, > 20 cigarettes/day % | 21.81 | 20.83 | 21.09 | 22.17 | 23.10 |
| Current, ≤ 20 cigarettes/day % | 8.61 | 8.78 | 8.63 | 8.30 | 8.68 |
| Current, > 20 cigarettes/day % | 5.11 | 4.61 | 5.41 | 5.03 | 5.42 |
| Education** | |||||
| High school or less % | 25.43 | 32.48 | 27.46 | 20.39 | 21.17 |
| Technical/some college % | 33.16 | 29.13 | 31.97 | 35.04 | 36.52 |
| College % | 18.97 | 17.24 | 19.40 | 20.06 | 19.33 |
| Postgraduate % | 20.02 | 18.90 | 18.75 | 22.12 | 20.38 |
| Physical activity throughout the day** | |||||
| Sit during day, not much walking % | 7.89 | 8.13 | 7.17 | 8.22 | 7.98 |
| Sit much of day, walk fair amount % | 32.32 | 32.71 | 30.46 | 33.46 | 32.55 |
| Stand/walk a lot, no lifting % | 37.61 | 34.78 | 37.50 | 38.58 | 39.62 |
| Lift/carry light loads % | 17.48 | 19.47 | 19.63 | 15.47 | 15.40 |
| Heavy work % | 2.88 | 2.86 | 3.39 | 2.68 | 2.63 |
| Vigorous physical activity** | |||||
| Never % | 4.22 | 4.76 | 4.19 | 3.86 | 4.04 |
| Rarely % | 13.42 | 15.00 | 13.16 | 12.63 | 12.77 |
| 1-3/month % | 13.59 | 14.78 | 13.69 | 13.25 | 12.64 |
| 1-2/week % | 21.73 | 22.61 | 22.43 | 21.39 | 20.55 |
| 3-4/week % | 26.88 | 25.35 | 27.25 | 27.69 | 27.36 |
| 5+/week % | 19.46 | 16.74 | 18.54 | 20.52 | 21.99 |
| Census tract median household income, mean (sd) | 54,477 (23,585) | 60,458 (24,826) | 49,598 (19,538) | 57,022 (26,431) | 50,640 (21,172) |
The July erythemal exposure was calculated as the averaged exposure across all available measured days in the month of July between 1978-1993 and 1996-2005
Due to missing data, percentages do not total 100%
Abbreviations: sd, standard deviation; J, joules; BMI, body mass index
All analyses were conducted using the software packages R (http://www.r-project.org/) and SAS 9.2 (SAS Institute, Cary, NC). Graphs were made using GraphPad Prism version 5.00 (GraphPad Software, San Diego, CA). We present both age- and multivariate-adjusted effect estimates. We interpreted p < 0.05 and 95% CIs excluding 1 as statistically significant.
Results
Table 1 presents the characteristics of the 450,934 participants by UVR exposure quartiles (176.1 - 186.3, >186.3 - 236.8, >236.8 - 253.7, and >253.7 - 289.5 J/m2). Figure 1 maps the UVR exposure and location of the participants.
Figure 1.
Map of ambient residential UVR exposure of participants in NIH-AARP Diet and Health Study cohort. Ground-level erythemal exposure for each participant was assigned by linking the census tract centroid of the self-reported residence at baseline to the closest point on the TOMS grid. The census tract for each subject was assigned spatially based on the longitude and latitude coordinates from geocoding residential address. The erythemal exposure was averaged across all available measured days in the month of July. The units are defined as joules per square meter (J/m2).
Among the non-melanoma skin cancer subset, ambient residential UVR exposure as a continuous variable was significantly associated with an increased non-melanoma skin cancer risk, OR (95%CI) = 1.25 (1.22, 1.28).
In the complete cohort, during a mean follow-up of 9.07 years (standard deviation 2.92 years), 75,917 incident cancer diagnoses were ascertained. When all cancers were combined, we found that the highest quartile of UVR exposure was inversely associated with total cancer risk (multivariate-adjusted HR (95% CI) = 0.97 (0.95, 0.99). Because of the known adverse effect of UVR on melanoma risk, we excluded melanoma cases (n=5,052), and the inverse association remained; we also excluded the large number of prostate cancer cases (n=21,439), and the inverse association remained, although was non-significant; the inverse association remained after the exclusion of both melanoma and prostate cancer cases (data not shown).
Supplementary Table 1 presents the age-adjusted estimates, and Table 2 presents the multivariate-adjusted estimates for the associations between ambient residential UVR exposure and site-specific cancer risk, listed by ICD-O code. We found that ambient residential UVR exposure was significantly associated with an increased risk of melanoma and other non-epithelial skin cancers, and the association was monotonic.
Table 2.
| July erythemal exposure (J/m2)*** |
|||||||
|---|---|---|---|---|---|---|---|
| ICD-O Code | Cancer site | Cases | ≤186.3 | >186.3-236.8 | >236.8-253.7 | >253.7 | p- trend |
| C00.0-C00.9 | Lip | 101 | 1.00 | 1.17 (0.62, 2.19) | 1.97 (1.13, 3.43) | 1.28 (0.71, 2.33) | 0.079 |
| C00.0-C06.9 | Oral | 745 | 1.00 | 0.90 (0.72, 1.12) | 1.17 (0.96, 1.44) | 1.10 (0.90, 1.35) | 0.079 |
| C02.4, C09.8,C09.9, C11.1,C14.2, C37.9,C42.2, C77.0-C77.9 |
Non-Hodgkin’s lymphoma (total) | 2,731 | 1.00 | 0.97 (0.87, 1.08) | 0.95 (0.85, 1.05) | 0.82 (0.74, 0.92) | 0.002 |
| Diffuse large B-cell lymphoma | 1,059 | 1.00 | 1.05 (0.89, 1.25) | 1.06 (0.90, 1.25) | 0.80 (0.67, 0.96) | 0.005 | |
| Follicular lymphoma | 577 | 1.00 | 0.87 (0.69, 1.09) | 0.77 (0.60, 0.97) | 0.85 (0.68, 1.07) | 0.161 | |
| Chronic lymphocytic leukemia/small lymphocytic lymphoma |
237 | 1.00 | 0.92 (0.63, 1.33) | 0.95 (0.66, 1.37) | 0.99 (0.70, 1.41) | 0.964 | |
| Other B-cell | 451 | 1.00 | 1.08 (0.84, 1.40) | 1.07 (0.82, 1.38) | 0.85 (0.65, 1.11) | 0.252 | |
| T-cell | 188 | 1.00 | 0.76 (0.51, 1.14) | 0.83 (0.57, 1.22) | 0.61 (0.41, 0.93) | 0.200 | |
| C09.0-C13.9 | Pharynx | 318 | 1.00 | 1.19 (0.86, 1.65) | 1.18 (0.84, 1.64) | 1.26 (0.91, 1.73) | 0.547 |
| C15.0-C15.9 | Esophageal adenocarcinoma | 607 | 1.00 | 0.90 (0.72, 1.13) | 0.99 (0.79, 1.24) | 0.92 (0.73, 1.14) | 0.732 |
| Esophageal squamous cell carcinoma | 190 | 1.00 | 0.84 (0.56, 1.26) | 0.94 (0.64, 1.39) | 0.63 (0.41, 0.95) | 0.114 | |
| C16.0-C16.9 | Stomach | 827 | 1.00 | 0.79 (0.65, 0.97) | 0.96 (0.79, 1.16) | 0.96 (0.79, 1.15) | 0.126 |
| C17.0-C17.9 | Small intestine | 220 | 1.00 | 0.99 (0.69, 1.44) | 0.77 (0.52, 1.14) | 0.91 (0.63, 1.31) | 0.555 |
| C18.0-C18.9, C26.0 | Colon | 5,133 | 1.00 | 0.98 (0.91, 1.06) | 0.96 (0.89, 1.04) | 0.88 (0.82, 0.96) | 0.011 |
| C20.9 | Rectum | 1,912 | 1.00 | 0.90 (0.79, 1.02) | 0.86 (0.75, 0.98) | 0.90 (0.80, 1.02) | 0.113 |
| C22.0, C22.1 | Liver | 498 | 1.00 | 1.16 (0.90, 1.50) | 1.02 (0.79, 1.33) | 1.18 (0.92, 1.52) | 0.444 |
| C23.9 | Gall bladder | 105 | 1.00 | 0.56 (0.32, 1.00) | 0.71 (0.42, 1.22) | 0.76 (0.46, 1.26) | 0.233 |
| C25.0-C25.9 | Pancreas | 1,598 | 1.00 | 0.91 (0.79, 1.05) | 0.79 (0.68, 0.91) | 0.95 (0.83, 1.09) | 0.009 |
| C30.0-C30.1, C31.0-C31.9, C32.0-C32.9, C34.0-C34.9, C38.4, C33.9, C38.1- C38.3, C38.8, C39.0, C39.8, C39.9 |
Lung (total) | 9,103 | 1.00 | 0.97 (0.91, 1.03) | 1.02 (0.96, 1.08) | 1.03 (0.97, 1.09) | 0.270 |
| Lung (adeno) | 3,766 | 1.00 | 0.87 (0.79, 0.95) | 0.94 (0.86, 1.03) | 0.98 (0.90, 1.07) | 0.013 | |
| Lung (squamous) | 1,861 | 1.00 | 0.92 (0.80, 1.05) | 1.02 (0.90, 1.16) | 0.86 (0.75, 0.98) | 0.030 | |
| Lung (other) | 4,118 | 1.00 | 1.07 (0.98, 1.17) | 1.06 (0.97, 1.16) | 1.11 (1.01, 1.21) | 0.159 | |
| C32.0-C32.9 | Larynx | 595 | 1.00 | 0.75 (0.59, 0.95) | 0.89 (0.71, 1.12) | 0.94 (0.76, 1.17) | 0.096 |
| C38.0, C47.0-C47.9, C49.0-C49.9 |
Soft tissue including heart | 280 | 1.00 | 1.61 (1.14, 2.27) | 1.29 (0.90, 1.84) | 1.38 (0.97, 1.95) | 0.057 |
| C38.4 | Pleura | 203 | 1.00 | 0.61 (0.41, 0.90) | 0.72 (0.50, 1.05) | 0.57 (0.38, 0.84) | 0.014 |
| C42.0, C42.1, C42.4 | Leukemia | 1,524 | 1.00 | 0.91 (0.79, 1.05) | 0.91 (0.79, 1.05) | 1.03 (0.90, 1.18) | 0.196 |
| C42.1 | Myeloma | 783 | 1.00 | 1.20 (0.99, 1.47) | 1.11 (0.91, 1.36) | 0.94 (0.76, 1.15) | 0.066 |
| C44.0-C44.9 | Melanoma & other non-epithelial skin cancer |
5,052 | 1.00 | 1.04 (0.95, 1.13) | 1.10 (1.02, 1.19) | 1.22 (1.13, 1.32) | <0.001 |
| C50.0-C50.9 | Breast | 8,681 | 1.00 | 0.99 (0.93, 1.05) | 1.05 (0.99, 1.12) | 1.03 (0.97, 1.09) | 0.198 |
| C54.0-C54.9, C55.9 | Uterus | 1,467 | 1.00 | 0.99 (0.85, 1.15) | 1.00 (0.87, 1.16) | 1.01 (0.88, 1.17) | 0.991 |
| C56.9 | Ovary | 648 | 1.00 | 1.14 (0.92, 1.42) | 0.92 (0.74, 1.16) | 0.93 (0.75, 1.17) | 0.209 |
| C61.9 | Prostate | 21,439 | 1.00 | 0.94 (0.91, 0.98) | 0.96 (0.92, 0.99) | 0.91 (0.88, 0.95) | <0.001 |
| C64.9, C65.9 | Kidney | 1,923 | 1.00 | 0.93 (0.82, 1.05) | 0.88 (0.77, 1.00) | 0.83 (0.73, 0.94) | 0.030 |
| C67.0-C67.9 | Bladder | 4,124 | 1.00 | 0.88 (0.81, 0.96) | 0.87 (0.80, 0.95) | 0.88 (0.81, 0.96) | 0.003 |
| C69.0-C69.9 | Eye | 151 | 1.00 | 1.42 (0.88, 2.29) | 1.14 (0.70, 1.88) | 1.53 (0.96, 2.42) | 0.256 |
| C71.0-C71.9 | Brain | 709 | 1.00 | 0.85 (0.68, 1.06) | 1.02 (0.83, 1.25) | 0.96 (0.78, 1.18) | 0.376 |
| C73.9 | Thyroid | 536 | 1.00 | 0.93 (0.73, 1.18) | 0.69 (0.54, 0.89) | 0.87 (0.69, 1.09) | 0.026 |
Hazard ratios (HRs) and 95% confidence intervals (CI) were calculated using Cox regression models adjusted for the following covariates: age at baseline, sex, BMI, caloric intake, intake of fruit, vegetables, and red and white meat, alcohol consumption, tobacco smoking, education, physical activity, median household income
Cancer sites with less than 100 cases are not shown here
The July erythemal exposure was calculated as the averaged exposure across all available measured days in the month of July between 1978-1993 and 1996-2005
Esophageal adenocarcinoma: 8140,8142, 8144, 8261, 8310, 8480, 8481, 8570, 8260, 8263, 8490; Esophageal squamous cell carcinoma: 8041, 8070,8071,8072, 8074
Cancers of the breast, uterus, and ovary were restricted to females; prostate cancer was restricted to males
The highest quartile of UVR exposure was significantly associated with decreased risks of NHL (including diffuse large B-cell lymphoma and T-cell lymphomas) and squamous cell lung cancer, and cancers of the colon, pleura, prostate, kidney, and bladder. In addition to these cancer sites, pancreatic and thyroid cancers and lung adenocarcinoma also had p-trend <0.05.
As a sensitivity analysis, we examined the association between UVR exposure and total cancer and site-specific cancer risks in subjects residing in California because residents had a wide range of UVR exposure and also comprised a large number of cancer cases. While effect estimates were similar to those found for the original cohort, they were less precise (data not shown).
Our analysis of UVR exposure in quartiles suggested potential non-linear relationships. For example, for pancreatic and thyroid cancers, the third quartile was significantly associated with decreased risk, but the highest quartile was not significant.
Therefore, we examined the possibility of non-linear associations. Using cubic spline analysis, we estimated a non-linear association between UVR exposure with squamous cell lung cancer, thyroid cancer, and pancreatic cancer risks. Figure 2 shows the estimated splines for some site-specific cancers. The spline analyses were concordant with our quartile analyses presented in Table 2.
Figure 2.
Restricted cubic spline analysis of UVR exposure and risk of selected site-specific cancers. Monotonic associations were observed for NHL and colon cancer. Non-linear associations were observed for melanoma, thyroid cancer, pancreatic cancer, and squamous cell lung cancer.
Discussion
We examined total and site-specific cancer risk in relation to ambient residential UVR exposure in a large prospective study in the US. We found a significant inverse association with total cancer risk. This association may in part be driven by the inverse association found for prostate cancer (28% of cases). These results should be interpreted with caution as the small effect sizes reflect the greatly varied risk patterns for individual cancers and are mainly driven by the large number of total cancer cases.
In analyses of individual cancer sites, we found a positive association with melanoma risk and an inverse association with risk of incident cancers at several sites, including NHL, colon, squamous cell lung, pleura, prostate, kidney, and bladder. We also found non-linear associations between UVR exposure and risk of pancreatic, thyroid, and squamous cell lung cancers. We detected several different patterns of association between the range of UVR exposure and cancer risk, which suggest that different biological mechanisms may be responsible for these associations. In this section, we discuss some of these cancer outcomes in the context of relevant previous studies and also assess the limitations and strengths of our study.
Although the association with other cancers is less clear, it is well established that sunlight or UVR exposure contributes to risk of melanoma 20 and non-melanoma skin cancer 21. As expected, we found a significantly increased risk with incident melanoma in our cohort. We had self-reported history of non-melanoma skin cancer in only a subset, and indeed, in a cross-sectional subset analysis, ambient residential UVR exposure was significantly associated with increased non-melanoma skin cancer risk. This statistically significant positive association strongly supported using the erythemal exposure from the TOMS dataset to assess ambient residential UVR exposure in relation to cancer outcomes in the NIH-AARP Diet and Health study cohort.
Many studies on UVR exposure and cancer risk have focused on NHL and cancers of the colon, prostate and female breast. We found inverse associations with risk of NHL and cancers of the colon and prostate, but not the breast.
Worldwide, the incidence of NHL has been increasing, and increased sunlight exposure has been proposed to be partly responsible 5, 22. Ecologic and observational studies have suggested that geographic residence and self-reported UVR exposure behaviors, respectively, may be positively 5, 23 or negatively 5, 24 correlated with NHL incidence. Although inconsistent 5, most studies have found an inverse association 25, and our prospective study, which controlled for potential confounders, contributes additional evidence. Some studies have suggested that this inverse association may be due to a mechanism independent of vitamin D 26-27.
UVR exposure was significantly associated with a monotonic decreased colon cancer risk. Previous ecologic and observational studies 3, 28-29 of sun exposure suggest a similar association. Our study, along with others that examine dietary or circulating vitamin D 30-32, adds support to the hypothesis that vitamin D is associated with colon cancer risk.
Our finding of a significant association between ambient residential UVR exposure and decreased prostate cancer risk is consistent with the hypothesis that sun exposure may be inversely associated with prostate cancer risk 1, 33-34; prostate cancer showed an inverse association at each quartile level and an apparent dose response. Mounting epidemiologic evidence on sun exposure supports this hypothesis 2, although results from less informative studies of dietary vitamin D and studies of circulating vitamin D are generally non-supportive, with some studies even suggesting an increased prostate cancer risk in those with the highest serum vitamin D values 35.
We found a significant non-linear association between ambient residential UVR exposure and pancreatic cancer risk. UVR exposure may play a role independent of vitamin D, as an adverse effect was apparent in a large consortia analysis of circulating vitamin D and pancreatic cancer risk 36. Further studies on UVR exposure and pancreatic cancer are warranted; assessment of populations with a wide range of personal UVR exposure or circulating serum vitamin D may help future studies clarify the molecular mechanisms of these associations.
Unlike previous studies 4, 37, we found no association between UVR exposure and breast cancer risk. Studies of vitamin D and breast cancer produced mixed results 38-39. We did find significant associations between UVR exposure and risk of squamous cell carcinoma and adenocarcinoma of the lung and cancers of the pleura, kidney, bladder, and thyroid. These associations have not been the focus of previous studies of UVR exposure and may be interesting for future explorations.
This study has several limitations. First, we did not have information on sun-related behaviors, such as sunscreen use or time spent outdoors. Ambient residential UVR exposure was calculated for each participant based on residence at baseline, and the spatial resolution of UVR exposure was limited in the TOMS dataset to grids of 1° latitude by 1.25° longitude, which represents about 111 km north to south and between 75 and 101 km east to west, depending on latitude. Participants were assigned the same erythemal exposure if they lived within the same grid. However, the use of the TOMS dataset provides some improvement over estimates based on latitude, and location of residence is more objective compared with measures of self-reported sun exposure behaviors. The dataset takes into account a variety of environmental factors that affect erythemal exposure, including cloud cover and automobile exhaust. Averaging the TOMS-estimated exposures over longer periods of time improves the agreement with measured ground-level UVR 16, and we used the TOMS-estimated exposures over several years. However, a known limitation of the TOMS estimate is the underestimation of the effect of aerosols 40, which is a very important consideration in the northeastern U.S and could bias our results toward the null.
Another limitation is that while the NIH-AARP Diet and Health Study is a large study, it is not geographically representative of the US population for UVR exposure. We used only the residence at baseline and did not consider population mobility; also, we could not take into account seasonal migrations of subjects, i.e., time spent in winters or summers in locations other than their residence at baseline, and migrating individuals may adopt different behaviors at alternative residence(s). We also do not have data on occupation or leisure time spent outdoors. The UVR at baseline may not be representative of early life sun exposure, and the etiologically relevant exposure periods are unknown; in addition, our results may not be generalizable to younger age groups.
Incomplete control for confounders may have influenced our results. Cancer screening practices and unaccounted cancer site-specific confounders may result in residual confounding. Regional variations exist for viruses and organisms linked with cancer, including hepatitis infection and liver cancer 41. We excluded all participants who did not self-identify as “white, non-Hispanic” (approximately 8% of the cohort, thus representing very small numbers of cancer events), but our racial grouping of the remaining participants does not sufficiently account for important regional ethnic variations as well as geographically variable degrees of racial mixing, all of which may reflect potential genetic and lifestyle factors that may be linked to UVR and cancer risk. In addition, we had no information on the range of skin pigmentation or skin types. Our results may not be generalizable to other racial/ethnic groups.
There are several strengths to our study. We used a very large prospective cohort, which avoided reverse causation, of participants with regional diversity and a large range of UVR exposures. We used an objective measure of exposure estimated from a residential address obtained prior to case ascertainment and valid classification of incident outcomes. A major advantage of our study compared with ecologic studies is that in our models, we adjusted for a large number of potential confounders, including individual-level BMI, tobacco use, and physical activity, although their inclusion did not substantially change the risk estimates. Moreover, dietary habits throughout the U.S. may vary, and we adjusted for food intake in dietary categories such as fruits, vegetables, and meats.
While UVR exposure and cancer risk may be explained through various mechanisms 9, several studies suggest that the molecular actions of vitamin D contribute to cancer prevention 42, and therefore, exposure to solar UVR radiation, which results in the cutaneous synthesis of most of the vitamin D in the human body, is important. Geographic location, particularly latitude used in several studies, is limited in determining vitamin D production 43, and indeed, even individuals in high UVR environments may not have sufficient levels of circulating vitamin D 44. We used the TOMS dataset, which is an improvement over several studies to better estimate ground-level erythemal exposure and also broadly encompasses the UV-B region (280-320 nm) that is responsible for the production of vitamin D 45. However, the TOMS dataset captures the UV-A (320-400 nm) wavelengths as well and does not consider the differences between UV-A and UV-B radiation wavelengths in their ability to initiate DNA damage, cell signaling pathways, and immune alterations 46. The TOMS dataset also does not consider human body geometry or that age decreases the ability to produce vitamin D 47; therefore, additional conversion factors may be needed to estimate more accurately the vitamin D production-relevant UVR exposures 48. Moreover, we could not adjust for vitamin D supplementation, which was uncommon in the mid 1990s 49, nor estimate dietary vitamin D intake in our cohort, although dietary intake is not as well correlated with serum vitamin D as sunlight exposure 50. Moreover, UVR exposure may be a proxy or marker of some other risk factor for cancer.
In summary, our results add to mounting evidence for the influential role of UVR exposure on cancer. We found that ambient residential UVR exposure was inversely associated with total cancer risk. We also observed that this measure of UVR exposure was associated with differential risks of some site-specific incident cancers and that several different patterns of association were evident in the data. Future studies may account for cumulative exposures through residential history, develop new techniques to capture individual exposures, or further examine associations with cancer sites that have not previously been well studied.
Supplementary Material
Novelty and impact of the work.
Few non-ecologic, prospective studies have examined the association between ultraviolet radiation (UVR) exposure and risk of cancer. We examined the association between estimated ground-level UVR exposure derived from NASA satellite data and risk of total and site-specific cancers in 450,934 subjects over 9 years of follow-up, while also considering individual-level confounders. We found associations with risk of total cancer (75,917 incident cancers) and cancers at specific sites, including several non-linear associations with some site-specific cancers.
Acknowledgements
This research was supported (in part) by the Intramural Research Program of the NIH, National Cancer Institute. Cancer incidence data from the Atlanta metropolitan area were collected by the Georgia Center for Cancer Statistics, Department of Epidemiology, Rollins School of Public Health, and Emory University. Cancer incidence data from California were collected by the California Department of Health Services, Cancer Surveillance Section. Cancer incidence data from the Detroit metropolitan area were collected by the Michigan Cancer Surveillance Program, Community Health Administration, and State of Michigan. The Florida cancer incidence data used in this report were collected by the Florida Cancer Data System (FCDC) under contract with the Florida Department of Health (FDOH). The views expressed herein are solely those of the authors and do not necessarily reflect those of the FCDC or FDOH. Cancer incidence data from Louisiana were collected by the Louisiana Tumor Registry, Louisiana State University Medical Center in New Orleans. Cancer incidence data from New Jersey were collected by the New Jersey State Cancer Registry, Cancer Epidemiology Services, New Jersey State Department of Health and Senior Services. Cancer incidence data from North Carolina were collected by the North Carolina Central Cancer Registry. Cancer incidence data from Pennsylvania were supplied by the Division of Health Statistics and Research, Pennsylvania Department of Health, Harrisburg, Pennsylvania. The Pennsylvania Department of Health specifically disclaims responsibility for any analyses, interpretations or conclusions. Cancer incidence data from Arizona were collected by the Arizona Cancer Registry, Division of Public Health Services, and Arizona Department of Health Services. Cancer incidence data from Texas were collected by the Texas Cancer Registry, Cancer Epidemiology and Surveillance Branch, Texas Department of State Health Services.
We are indebted to the participants in the NIH-AARP Diet and Health Study for their outstanding cooperation. We also thank Sigurd Hermansen and Kerry Grace Morrissey from Westat for study outcomes ascertainment and management and Leslie Carroll and Mike Spriggs at Information Management Services for data support.
Financial Disclosure This work was supported by the Intramural Research Program of the Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Abbreviations
- (UVR)
ultraviolet radiation
- (TOMS)
Total Ozone Mapping Spectrometer
- (NASA)
National Aeronautics and Space Administration
- (HR)
hazard ratios
- (ORs)
odds ratios
- (CI)
confidence intervals
- (NHL)
non-Hodgkin’s lymphoma
- (NIH)
National Institutes of Health
- (BMI)
body mass index
- (sd)
standard deviation
- (J)
joules
Footnotes
Competing Interests The authors declare that no competing interests exist.
References
- 1.Grant WB. Anticancer Res. 2012;32:223–36. [PubMed] [Google Scholar]
- 2.Donkena KV, Young CYF. Vitamin D, Sunlight and Prostate Cancer Risk. Advances in Preventive Medicine. 2011:2011. doi: 10.4061/2011/281863. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Freedman DM, Rajaraman P, Fuhrman B, Hoffbeck R, Alexander BH. Sunlight, hormone replacement status and colorectal cancer risk in postmenopausal women. Int J Cancer. 2010;126:1997–2001. doi: 10.1002/ijc.24903. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.John EM, Schwartz GG, Dreon DM, Koo J. Vitamin D and breast cancer risk: The NHANES I Epidemiologic Follow-up Study, 1971–1975 to 1992. Cancer Epidemiology Biomarkers & Prevention. 1999;8:399–406. [PubMed] [Google Scholar]
- 5.Armstrong BK, Kricker A. Sun Exposure and Non-Hodgkin Lymphoma. Cancer Epidemiology Biomarkers & Prevention. 2007;16:396–400. doi: 10.1158/1055-9965.EPI-06-1068. [DOI] [PubMed] [Google Scholar]
- 6.Garland CF, Garland FC, Gorham ED, Lipkin M, Newmark H, Mohr SB, Holick MF. The role of vitamin D in cancer prevention. Am J Public Health. 2006;96:252–61. doi: 10.2105/AJPH.2004.045260. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. The American Journal of Clinical Nutrition. 2004;80:1678S–88S. doi: 10.1093/ajcn/80.6.1678S. [DOI] [PubMed] [Google Scholar]
- 8.Dietary Reference Intakes for Calcium and Vitamin D. Institute of Medicine; 2011. [Google Scholar]
- 9.Lucas RM, Ponsonby A-L. Considering the potential benefits as well as adverse effects of sun exposure: Can all the potential benefits be provided by oral vitamin D supplementation? Progress in Biophysics and Molecular Biology. 2006;92:140–9. doi: 10.1016/j.pbiomolbio.2006.02.019. [DOI] [PubMed] [Google Scholar]
- 10.Grant WB, Garland CF. The association of solar ultraviolet B (UVB) with reducing risk of cancer: multifactorial ecologic analysis of geographic variation in age-adjusted cancer mortality rates. Anticancer Res. 2006;26:2687–99. [PubMed] [Google Scholar]
- 11.Schwartz G, Hanchette C. UV, latitude, and spatial trends in prostate cancer mortality: All sunlight is not the same (United States) Cancer Causes and Control. 2006;17:1091–101. doi: 10.1007/s10552-006-0050-6. [DOI] [PubMed] [Google Scholar]
- 12.Grant WB. An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation. Cancer. 2002;94:1867–75. doi: 10.1002/cncr.10427. [DOI] [PubMed] [Google Scholar]
- 13.Schatzkin A, Subar AF, Thompson FE, Harlan LC, Tangrea J, Hollenbeck AR, Hurwitz PE, Coyle L, Schussler N, Michaud DS, Freedman LS, Brown CC, et al. Design and serendipity in establishing a large cohort with wide dietary intake distributions : the National Institutes of Health-American Association of Retired Persons Diet and Health Study. Am J Epidemiol. 2001;154:1119–25. doi: 10.1093/aje/154.12.1119. [DOI] [PubMed] [Google Scholar]
- 14.Michaud DS, Midthune D, Hermansen S, Leitzmann M, Harlan LC, Kipnis V, Schatzkin A. Comparison of cancer registry case ascertainment with SEER estimates and self-reporting in a subset of the NIH-AARP Diet and Health Study. Journal of Registry Management. 2005;32:70–5. [Google Scholar]
- 15.Ziemke JR, Chandra S, Herman J, Varotsos C. Erythemally weighted UV trends over northern latitudes derived from Nimbus 7 TOMS measurements. J. Geophys. Res. 2000;105:7373–82. [Google Scholar]
- 16.Kalliskota S, Kaurola J, Taalas P, Herman JR, Celarier EA, Krotkov NA. Comparison of daily UV doses estimated from Nimbus 7/TOMS measurements and ground-based spectroradiometric data. J. Geophys. Res. 2000;105:5059–67. [Google Scholar]
- 17.Herman JR, Krotkov N, Celarier E, Larko D, Labow G. Distribution of UV radiation at the Earth’s surface from TOMS-measured UV-backscattered radiances. J. Geophys. Res. 1999;104:12059–76. [Google Scholar]
- 18.Wood SN. Generalized additive models: An introduction with Red. Hall/CRC Press; 2006. [Google Scholar]
- 19.Durrleman S, Simon R. Flexible regression models with cubic splines. Statistics in Medicine. 1989;8:551–61. doi: 10.1002/sim.4780080504. [DOI] [PubMed] [Google Scholar]
- 20.Tucker MA. Is sunlight important to melanoma causation? Cancer Epidemiology Biomarkers & Prevention. 2008;17:467–8. doi: 10.1158/1055-9965.EPI-07-2743. [DOI] [PubMed] [Google Scholar]
- 21.Leiter U, Garbe C. Epidemiology of melanoma and nonmelanoma skin cancer--the role of sunlight. Adv Exp Med Biol. 2008;624:89–103. doi: 10.1007/978-0-387-77574-6_8. [DOI] [PubMed] [Google Scholar]
- 22.Mueller N. Another view of the epidemiology of non-Hodgkin’s lymphoma. Oncology. Vol. 8. Williston Park: 1994. p. 83. [PubMed] [Google Scholar]
- 23.Zhang Y, Holford TR, Leaderer B, Boyle P, Zhu Y, Wang R, Zou K, Zhang B, Wise JP, Qin Q, Kilfoy B, Han J, et al. Ultraviolet Radiation Exposure and Risk of Non-Hodgkin’s Lymphoma. American Journal of Epidemiology. 2007;165:1255–64. doi: 10.1093/aje/kwm020. [DOI] [PubMed] [Google Scholar]
- 24.Hu S, Ma F, Collado-Mesa F, Kirsner RS. Ultraviolet radiation and incidence of Non-Hodgkin’s Lymphoma among Hispanics in the United States. Cancer Epidemiology Biomarkers & Prevention. 2004;13:59–64. doi: 10.1158/1055-9965.epi-03-0187. [DOI] [PubMed] [Google Scholar]
- 25.Kricker A, Armstrong BK, Hughes AM, Goumas C, Smedby KE, Zheng T, Spinelli JJ, De Sanjosé S, Hartge P, Melbye M, Willett EV, Becker N, et al. Personal sun exposure and risk of non Hodgkin lymphoma: A pooled analysis from the Interlymph Consortium. International Journal of Cancer. 2008;122:144–54. doi: 10.1002/ijc.23003. [DOI] [PubMed] [Google Scholar]
- 26.Purdue MP, Freedman DM, Gapstur SM, Helzlsouer KJ, Laden F, Lim U, Maskarinec G, Rothman N, Shu X-O, Stevens VL, Zeleniuch-Jacquotte A, Albanes D, et al. Circulating 25-Hydroxyvitamin D and Risk of Non-Hodgkin Lymphoma. American Journal of Epidemiology. 2010;172:58–69. doi: 10.1093/aje/kwq117. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Chang ET, Canchola AJ, Cockburn M, Lu Y, Wang SS, Bernstein L, Clarke CA, Horn-Ross PL. Adulthood residential ultraviolet radiation, sun sensitivity, dietary vitamin D, and risk of lymphoid malignancies in the California Teachers Study. Blood. 2011;118:1591–9. doi: 10.1182/blood-2011-02-336065. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Emerson JC, Weiss NS. Colorectal cancer and solar radiation. Cancer Causes Control. 1992;3:95–9. doi: 10.1007/BF00051919. [DOI] [PubMed] [Google Scholar]
- 29.Chen W, Clements M, Rahman B, Zhang S, Qiao Y, Armstrong B. Relationship between cancer mortality/incidence and ambient ultraviolet B irradiance in China. Cancer Causes and Control. 2010;21:1701–9. doi: 10.1007/s10552-010-9599-1. [DOI] [PubMed] [Google Scholar]
- 30.Garland C, Barrett-Connor E, Rossof A, Shekelle R, Criqui M, Paul O. Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men. The Lancet. 1985;325:307–9. doi: 10.1016/s0140-6736(85)91082-7. [DOI] [PubMed] [Google Scholar]
- 31.Garland CF, Comstock GW, Garland FC, Helsing KJ, Shaw EK, Gorham ED. Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet. 1989;2:1176–8. doi: 10.1016/s0140-6736(89)91789-3. [DOI] [PubMed] [Google Scholar]
- 32.Giovannucci E. Epidemiological evidence for vitamin D and colorectal cancer. Journal of Bone and Mineral Research. 2007;22:V81–V5. doi: 10.1359/jbmr.07s206. [DOI] [PubMed] [Google Scholar]
- 33.Hanchette CL, Schwartz GG. Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation. Cancer. 1992;70:2861–9. doi: 10.1002/1097-0142(19921215)70:12<2861::aid-cncr2820701224>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
- 34.Loke TW, Sevfi D, Khadra M. Prostate cancer incidence in Australia correlates inversely with solar radiation. BJU International. 2011;108:66–70. doi: 10.1111/j.1464-410X.2011.10736.x. [DOI] [PubMed] [Google Scholar]
- 35.Albanes D, Mondul AM, Yu K, Parisi D, Horst RL, Virtamo J, Weinstein SJ. Serum 25-Hydroxy Vitamin D and Prostate Cancer Risk in a Large Nested Case—Control Study. Cancer Epidemiology Biomarkers & Prevention. 2011;20:1850–60. doi: 10.1158/1055-9965.EPI-11-0403. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Stolzenberg-Solomon RZ, Jacobs EJ, Arslan AA, Qi D, Patel AV, Helzlsouer KJ, Weinstein SJ, McCullough ML, Purdue MP, Shu X-O, Snyder K, Virtamo J, et al. Circulating 25-Hydroxyvitamin D and Risk of Pancreatic Cancer. American Journal of Epidemiology. 2010;172:81–93. doi: 10.1093/aje/kwq120. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Gorham ED, Garland FC, Garland CF. Sunlight and breast cancer incidence in the USSR. International Journal of Epidemiology. 1990;19:820–4. doi: 10.1093/ije/19.4.820. [DOI] [PubMed] [Google Scholar]
- 38.Chlebowski RT. Vitamin D and breast cancer: interpreting current evidence. Breast Cancer Res. 2011;13:217. doi: 10.1186/bcr2846. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Engel P, Fagherazzi G, Boutten A, Dupré T, Mesrine S, Boutron-Ruault M-C, Clavel-Chapelon F. Serum 25(OH) Vitamin D and Risk of Breast Cancer: A Nested Case-Control Study from the French E3N Cohort. Cancer Epidemiology Biomarkers & Prevention. 2010;19:2341–50. doi: 10.1158/1055-9965.EPI-10-0264. [DOI] [PubMed] [Google Scholar]
- 40.McKenzie RL, Seckmeyer G, Bais AF, Kerr JB, Madronich S. Satellite retrievals of erythemal UV dose compared with ground-based measurements at northern and southern midlatitudes. J. Geophys. Res. 2001;106:24051–62. [Google Scholar]
- 41.El-Serag HB. Epidemiology of hepatocellular carcinoma in USA. Hepatology Research. 2007;37:S88–S94. doi: 10.1111/j.1872-034X.2007.00168.x. [DOI] [PubMed] [Google Scholar]
- 42.Fleet JC. Molecular actions of vitamin D contributing to cancer prevention. Mol Aspects Med. 2008;29:388–96. doi: 10.1016/j.mam.2008.07.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Kimlin MG. Geographic location and vitamin D synthesis. Mol Aspects Med. 2008;29:453–61. doi: 10.1016/j.mam.2008.08.005. [DOI] [PubMed] [Google Scholar]
- 44.Kimlin M, Harrison S, Nowak M, Moore M, Brodie A, Lang C. Does a high UV environment ensure adequate vitamin D status? J Photochem Photobiol B. 2007;89:139–47. doi: 10.1016/j.jphotobiol.2007.09.008. [DOI] [PubMed] [Google Scholar]
- 45.MacLaughlin J, Anderson R, Holick M. Spectral character of sunlight modulates photosynthesis of previtamin D3 and its photoisomers in human skin. Science. 1982;216:1001–3. doi: 10.1126/science.6281884. [DOI] [PubMed] [Google Scholar]
- 46.De Fabo EC, Noonan FP, Fears T, Merlino G. Ultraviolet B but not ultraviolet A radiation initiates melanoma. Cancer Research. 2004;64:6372–6. doi: 10.1158/0008-5472.CAN-04-1454. [DOI] [PubMed] [Google Scholar]
- 47.MacLaughlin J, Holick MF. Aging decreases the capacity of human skin to produce vitamin D3. The Journal of Clinical Investigation. 1985;76:1536–8. doi: 10.1172/JCI112134. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Pope SJ, Holick MF, Mackin S, Godar DE. Action spectrum conversion factors that change erythemally weighted to previtamin D3-weighted UV doses. Photochem Photobiol. 2008;84:1277–83. doi: 10.1111/j.1751-1097.2008.00373.x. [DOI] [PubMed] [Google Scholar]
- 49.Gahche J, Bailey R, Burt V, Hughes J, Yetley E, Dwyer J, Picciano MF, McDowell M, Sempos C. Dietary supplement use among U.S. adults has increased since NHANES III (1988–1994) NCHS Data Brief. 2011;vol. 61 [PubMed] [Google Scholar]
- 50.McCullough ML, Weinstein SJ, Freedman DM, Helzlsouer K, Flanders WD, Koenig K, Kolonel L, Laden F, Le Marchand L, Purdue M, Snyder K, Stevens VL, et al. Correlates of Circulating 25-Hydroxyvitamin D. American Journal of Epidemiology. 2010;172:21–35. doi: 10.1093/aje/kwq113. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.


